TP53 and cancer: Interestingly, there are reports of various master regulators identified in our research, including JUN, STAT3, NFkB, TRP53, FOS, E2F1, and MyC, as modulators that affect cell proliferation, apoptosis, inflammatory activity, and tumor angiogenesis in various human cancer models [66,70,72].